- Home
- SRPT vs BSAC Comparison
SRPT vs BSAC Comparison
Compare SRPT & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- BSAC
- Stock Information
- Founded
- SRPT 1980
- BSAC 1977
- Country
- SRPT United States
- BSAC Chile
- Employees
- SRPT N/A
- BSAC N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- BSAC Commercial Banks
- Sector
- SRPT Health Care
- BSAC Finance
- Exchange
- SRPT Nasdaq
- BSAC Nasdaq
- Market Cap
- SRPT 9.8B
- BSAC 10.4B
- IPO Year
- SRPT 1997
- BSAC 1994
- Fundamental
- Price
- SRPT $70.40
- BSAC $23.09
- Analyst Decision
- SRPT Buy
- BSAC Hold
- Analyst Count
- SRPT 21
- BSAC 3
- Target Price
- SRPT $164.05
- BSAC $21.33
- AVG Volume (30 Days)
- SRPT 2.2M
- BSAC 368.1K
- Earning Date
- SRPT 04-30-2025
- BSAC 04-29-2025
- Dividend Yield
- SRPT N/A
- BSAC 3.23%
- EPS Growth
- SRPT N/A
- BSAC 47.20
- EPS
- SRPT 2.34
- BSAC 0.00
- Revenue
- SRPT $1,901,979,000.00
- BSAC $2,115,487,917.00
- Revenue This Year
- SRPT $67.83
- BSAC $37.67
- Revenue Next Year
- SRPT $25.66
- BSAC $5.96
- P/E Ratio
- SRPT $30.71
- BSAC $12.97
- Revenue Growth
- SRPT 52.97
- BSAC 31.30
- 52 Week Low
- SRPT $70.91
- BSAC $17.73
- 52 Week High
- SRPT $173.25
- BSAC $23.80
- Technical
- Relative Strength Index (RSI)
- SRPT 28.10
- BSAC 61.14
- Support Level
- SRPT $70.91
- BSAC $22.68
- Resistance Level
- SRPT $76.67
- BSAC $23.80
- Average True Range (ATR)
- SRPT 4.03
- BSAC 0.42
- MACD
- SRPT -1.50
- BSAC 0.00
- Stochastic Oscillator
- SRPT 2.28
- BSAC 78.57
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About BSAC Banco Santander - Chile ADS
Founded in 1978, Banco Santander Chile is part of the Santander group and majority controlled by Santander Spain. Banco Santander is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-sized companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country LATAM Chile.